Literature DB >> 19249644

Cancer stem cells in solid tumors: an overview.

Catherine Adell O'Brien1, Antonija Kreso, John E Dick.   

Abstract

It has long been appreciated that significant functional and morphologic heterogeneity can exist within the individual cells that comprise a tumor. Increasing evidence indicates that many solid tumors are organized in a hierarchical manner in which tumor growth is driven by a small subset of cancer stem cells (CSCs) or tumor-initiating cells. Although these cells represent a small percentage of the overall tumor population, they are the only cells capable of initiating and driving tumor growth. Emerging evidence indicates that these cells are also resistant to chemotherapy and radiation therapy, which has led to much speculation and interest surrounding the potential clinical applicability of CSCs.

Entities:  

Mesh:

Year:  2009        PMID: 19249644     DOI: 10.1016/j.semradonc.2008.11.001

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  80 in total

1.  Evidence for the osteosarcoma stem cell.

Authors:  C Parker Gibbs; Padraic P Levings; Steven C Ghivizzani
Journal:  Curr Orthop Pract       Date:  2011-07

2.  Cancer Stem Cells in the Immune Microenvironment.

Authors:  Dong-Sup Lee; Keunhee Oh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Sam68 Offers Selectively Aimed Modulation of Transcription in Cancer Stem Cells.

Authors:  Kai Fu; Fengyi Wan
Journal:  Cell Chem Biol       Date:  2017-07-20       Impact factor: 8.116

4.  CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity.

Authors:  Cheng-Jian Shi; Jun Gao; Min Wang; Xin Wang; Rui Tian; Feng Zhu; Ming Shen; Ren-Yi Qin
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

5.  ABCC2 (MRP2, cMOAT) localized in the nuclear envelope of breast carcinoma cells correlates with poor clinical outcome.

Authors:  Adam Maciejczyk; Ewa Jagoda; Teresa Wysocka; Rafał Matkowski; Balázs Györffy; Hermann Lage; Paweł Surowiak
Journal:  Pathol Oncol Res       Date:  2011-10-11       Impact factor: 3.201

6.  Overexpression of HSBP1 is associated with resistance to radiotherapy in oral squamous epithelial carcinoma.

Authors:  Lanhua Shen; Rui Zhang; Yi Sun; Xin Wang; An-Mei Deng; Liangjia Bi
Journal:  Med Oncol       Date:  2014-05-11       Impact factor: 3.064

7.  Radiosensitivity of pimonidazole-unlabelled intratumour quiescent cell population to γ-rays, accelerated carbon ion beams and boron neutron capture reaction.

Authors:  S Masunaga; Y Sakurai; H Tanaka; R Hirayama; Y Matsumoto; A Uzawa; M Suzuki; N Kondo; M Narabayashi; A Maruhashi; K Ono
Journal:  Br J Radiol       Date:  2013-01       Impact factor: 3.039

8.  Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.

Authors:  Christine E Brown; Renate Starr; Catalina Martinez; Brenda Aguilar; Massimo D'Apuzzo; Ivan Todorov; Chu-Chih Shih; Behnam Badie; Michael Hudecek; Stanley R Riddell; Michael C Jensen
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

9.  Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.

Authors:  Gérald J Prud'homme; Yelena Glinka; Anna Toulina; Olga Ace; Venkateswaran Subramaniam; Serge Jothy
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

Review 10.  The hallmarks of premalignant conditions: a molecular basis for cancer prevention.

Authors:  Bríd M Ryan; Jessica M Faupel-Badger
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.